학술논문
Final results of a phase I/II prospective dose escalation trial evaluating safety and efficacy of combination 177Lu PSMA 617 and NOX66 in men with end-stage metastatic castration-resistant prostate cancer (LuPIN trial)
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15277755